Follow-The-Filings

Security

ANIP

Ani Pharmaceuticals Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

10 owners 1 new 3 exits max 0.0% (Israel Englander - Millen...)

grid → activity →
owners 10
max % 0.0%
tracked value $207M
qoq N 1 A 4 R 3 E 3

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 592,013 $46M hist
Renaissance Technologies LLC 2026 Q1 0.0% Reduce -0.02 pp 186,102 $14M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.02 pp 181,151 $14M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 213,433 $16M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.0% Reduce 0.00 pp 24,095 $2M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 1,305,068 $103M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 115,082 $9M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 18,842 $1M hist
Norges Bank 2025 Q4 stale 0.0% Exit 0.00 pp 9,585 $757 hist
Polen Capital Management LLC 2026 Q1 0.0% New 0.0% 6,409 $493 hist
Dmitry Balyasny - Balyasny Asset Management L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit -0.02 pp 205,089 $16M hist
Steve Cohen - Point72 Asset Management, L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit -0.01 pp 121,211 $10M hist
Marshall Wace - Marshall Wace, LLP exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 5,518 $436 hist

10 current · 3 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $486.82M $614.38M $883.37M
Gross profit — — —
Gross margin — — —
Net income $18.78M -$18.52M $78.34M
Net margin * 3.9% -3.0% 8.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $519.82M $527.68M $753.12M
Total non-current assets * $384.61M $756.01M $687.26M
Total assets $904.42M $1.28B $1.44B
Total current liabilities $145.48M $193.68M $278.11M
Total non-current liabilities * $301.35M $661.49M $621.54M
Total equity $432.75M $403.68M $540.72M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $118.96M $64.02M $185.22M
Cash from investing -$18.51M -$404.72M -$34.32M
Cash from financing $67.44M $264.94M -$9.94M
Net change in cash $167.89M -$76.23M $140.73M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders